Escherichia coli Vaccines
"Escherichia coli Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines or candidate vaccines used to prevent or treat both enterotoxigenic and enteropathogenic Escherichia coli infections.
| Descriptor ID |
D022361
|
| MeSH Number(s) |
D20.215.894.135.390
|
| Concept/Terms |
Escherichia coli Vaccines- Escherichia coli Vaccines
- Vaccines, Escherichia coli
- E coli Vaccines
- Vaccines, E coli
- Escherichia coli Vaccine
- Vaccine, Escherichia coli
|
Below are MeSH descriptors whose meaning is more general than "Escherichia coli Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Escherichia coli Vaccines".
This graph shows the total number of publications written about "Escherichia coli Vaccines" by people in this website by year, and whether "Escherichia coli Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Escherichia coli Vaccines" by people in Profiles.
-
Vaccines against extraintestinal pathogenic Escherichia coli (ExPEC): progress and challenges. Gut Microbes. 2024 Jan-Dec; 16(1):2359691.
-
Progress toward a vaccine for extraintestinal pathogenic E. coli (ExPEC) II: efficacy of a toxin-autotransporter dual antigen approach. Infect Immun. 2024 May 07; 92(5):e0044023.
-
Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala. Lancet Infect Dis. 2014 Mar; 14(3):197-204.
-
Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. Lancet. 2008 Jun 14; 371(9629):2019-25.
-
Safety and efficacy of E coli enterotoxin adjuvant for urease-based rectal immunization against Helicobacter pylori. Vaccine. 2002 Dec 13; 21(3-4):194-201.